http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#Head
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#assertion
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#provenance
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#pubinfo
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#assertion
http://purl.obolibrary.org/obo/DOID_9074
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_9074
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01611
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association
http://www.w3.org/2000/01/rdf-schema#label
malaria hydroxychloroquine sulfate tablets are indicated for the treatment of uncomplicated malaria due to p falciparum p malariae p ovale p vivax hydroxychloroquine sulfate tablets are indicated for the prophylaxis of malaria in geographic areas where chloroquine resistance is not reported limitations of use in malaria hydroxychloroquine sulfate tablets are not recommended for the treatment of complicated malaria hydroxychloroquine sulfate tablets are not effective against chloroquine or hydroxychloroquine resistant strains of plasmodium clinical pharmacology microbiology plasmodium hydroxychloroquine sulfate tablets are not recommended for malaria prophylaxis in geographic areas where chloroquine resistance occurs hydroxychloroquine sulfate tablets do not prevent relapses of p vivax p ovale p vivax p ovale clinical pharmacology microbiology prior to prescribing hydroxychloroquine sulfate tablets for the treatment or prophylaxis of malaria consult the centers for disease control and prevention cdc malaria website http www cdc gov malaria lupus erythematosus hydroxychloroquine sulfate tablets are indicated for the treatment of chronic discoid lupus erythematosus and systemic lupus erythematosus in adults rheumatoid arthritis hydroxychloroquine sulfate tablets are indicated for the treatment of acute and chronic rheumatoid arthritis in adults
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB01611
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#provenance
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#pubinfo
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#sig
http://purl.org/nanopub/x/hasSignature
co5nkSVsbhNLqGDvAqEb0SYKaqorWrt5qvHS58xQ+W82Cr+slLAU1ynuvceE/TacPT1qEn+mJQfd38IQjA7b7HgTF8w0sDHjgd4IBRJPbNZH6F8ERhewSd+W3py6Uo9pkr4ldgcGQD5+guRxjZ0Jx1364r51klEYiKx2v/rbHW4=
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
http://purl.org/dc/terms/created
2021-06-15T18:42:22.763+02:00
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs